APA

Kazianka L., Drucker C., Skrabs C., Thomas W., Melchardt T., Struve S., Bergmann M., Staber P. B., Porpaczy E., Einberger C., Heinz M., Hauswirth A., Raderer M., Pabinger I., Thalhammer R., Egle A., Wendtner C., Follows G., Hoermann G., Quehenberger P., Jilma B. & Jaeger U. (20170912). Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib. : Leukemia.

Chicago

Kazianka L, Drucker C, Skrabs C, Thomas W, Melchardt T, Struve S, Bergmann M, Staber P B, Porpaczy E, Einberger C, Heinz M, Hauswirth A, Raderer M, Pabinger I, Thalhammer R, Egle A, Wendtner C-M, Follows G, Hoermann G, Quehenberger P, Jilma B and Jaeger U. 20170912. Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib. : Leukemia.

Harvard

Kazianka L., Drucker C., Skrabs C., Thomas W., Melchardt T., Struve S., Bergmann M., Staber P. B., Porpaczy E., Einberger C., Heinz M., Hauswirth A., Raderer M., Pabinger I., Thalhammer R., Egle A., Wendtner C., Follows G., Hoermann G., Quehenberger P., Jilma B. and Jaeger U. (20170912). Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib. : Leukemia.

MLA

Kazianka L, Drucker C, Skrabs C, Thomas W, Melchardt T, Struve S, Bergmann M, Staber P B, Porpaczy E, Einberger C, Heinz M, Hauswirth A, Raderer M, Pabinger I, Thalhammer R, Egle A, Wendtner C-M, Follows G, Hoermann G, Quehenberger P, Jilma B and Jaeger U. Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib. : Leukemia. 20170912.